MedSci Healthcare Holdings Limited submitted its Monthly Return for Equity Issuers to the Hong Kong Stock Exchange on 3 June 2026, covering movements for the month ended 31 May 2026.

The company’s authorised share capital remained unchanged at 15.00 billion ordinary shares with a par value of USD 0.0001 each, amounting to total authorised capital of USD 1.50 million.

Issued share capital was steady at 607.17 million ordinary shares, with no treasury shares outstanding or movements recorded during the month. Consequently, the total number of issued shares also stayed at 607.17 million.

MedSci confirmed that it continues to meet the Main Board’s minimum public-float requirement of 25 percent of issued shares.

The filing shows no activity under share option schemes, warrants, convertible securities, or other equity-linked instruments, and there were no Hong Kong Depositary Receipts or share repurchases.

The submission was authorised and signed by Executive Director Dr. Zhang Fabao, who affirmed full compliance with all relevant Hong Kong listing rules and regulatory obligations.